Prognostic significance of the s-phase fraction of light-chain- restricted cytoplasmic immunoglobulin (clg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486

M. C. Trendle, T. Leong, R. A. Kyle, J. A. Katzmann, M. M. Oken, N. E. Kay, B. G. Van Ness, Philip R. Greipp

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic significance of the s-phase fraction of light-chain- restricted cytoplasmic immunoglobulin (clg) positive plasma cells in patients with newly diagnosed multiple myeloma enrolled on Eastern Cooperative Oncology Group treatment trial E9486'. Together they form a unique fingerprint.

Medicine & Life Sciences